Literature DB >> 8934921

Sjögren's syndrome: immunobiology of exocrine gland dysfunction.

R I Fox1.   

Abstract

Sjögren's syndrome is an autoimmune disorder characterized by dryness of the eyes and mouth. The frequency of this disorder remains controversial, due to absence of a universally accepted classification system. In the San Diego and San Francisco classification systems for primary Sjögren's syndrome, evidence for an autoimmune process and focal lymphocytic infiltration of the salivary or lacrimal gland is required for diagnosis. This paper reviews the genetic and environmental factors that have been associated with the autoimmune process in Sjögren's syndrome. Key immunopathologic features include: (a) an increased prevalence of particular HLA-DR/DQ alleles; (b) induction of HLA-DR/DQ proteins on the epithelial cells in salivary and lacrimal gland biopsies; (c) infiltration of the glands by CD4+ T-cells that transcribe IL-2 and IFN-gamma; (d) induction of granzyme A and perforin in CD4+ T-cells, suggesting a mechanism of cellular destruction of the glands; (e) clonal expansion of B-cells that use a particular light chain within the salivary gland; (f) production of autoantibodies against nuclear antigens SS-A (60 and 52 kDa) and SS-B (48 kDa), indicating a failure of normal tolerance mechanisms; and (g) increased frequency of B-cell non-Hodgkin's lymphoma. Indirect evidence has suggested a potential role for viruses (especially members of the herpesvirus and retroviral family) as co-factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934921     DOI: 10.1177/08959374960100010601

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  6 in total

1.  P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

Authors:  Olga J Baker; Jean M Camden; Danny E Rome; Cheikh I Seye; Gary A Weisman
Journal:  Mol Immunol       Date:  2007-06-27       Impact factor: 4.407

2.  Modeling Sjögren's syndrome with Id3 conditional knockout mice.

Authors:  Zengli Guo; Hongmei Li; Min Han; Tian Xu; Xiaohui Wu; Yuan Zhuang
Journal:  Immunol Lett       Date:  2011-03-30       Impact factor: 3.685

3.  Pathogenic mechanisms in systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

4.  Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren's syndrome: possible markers for a common secretory disorder.

Authors:  Antonia Szanto; Istvan Csipo; Ildiko Horvath; Edit Biro; Peter Szodoray; Margit Zeher
Journal:  Rheumatol Int       Date:  2008-04-23       Impact factor: 2.631

5.  Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.

Authors:  T Nishiyama; K Mishima; K Obara; H Inoue; T Doi; S Kondo; M Saka; Y Tabunoki; Y Hattori; T Kodama; K Tsubota; I Saito
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

Review 6.  Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.

Authors:  Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.